Αποτελέσματα Αναζήτησης
1 Ιουλ 2020 · Presentation of Case. Dr. Aditya Bardia: A 62-year-old woman was evaluated at this hospital after she had identified a mass in her left breast, confirmed by her physician on physical examination,...
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Evolution and prognostic significance of HER-2 conversion...
- 20-Year Risks of Breast-Cancer Recurrence After Stopping Endocrine Therapy at 5 Years
During the study period from 5 to 20 years, the absolute...
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Prediction of Oncotype DX Recurrence Score Based on...
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
The RASTER (Microarray Prognostics in Breast Cancer) study...
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
5 Απρ 2011 · This case study discusses two patients with locally advanced Merkel cell carcinoma. The authors describe how neoadjuvant polychemotherapy was used to treat these patients allowing...
Current Problems in Cancer: Case Reports is an international, peer-reviewed open access Journal publishing oncology case reports. It aims to share awareness of groundbreaking cases that give insight into redefining concepts in cancer.
5 Ιουν 2024 · A 45-year-old woman was evaluated in the oncology clinic of the hospital because of metastatic triple-negative breast cancer that had progressed despite chemotherapy. Management decisions were...
28 Μαρ 2022 · The current study suggests that there is a small subset of patients (~2%) with advanced metastatic disease whose tumors still demonstrate only single pathway alterations on NGS, and that such ...
25 Σεπ 2019 · Figure 1. Initial Imaging Studies of the Chest, Obtained before the Lung Cancer Diagnosis. A biopsy specimen of the lung mass showed evidence of lung adenocarcinoma with a mutation in KRAS.
19 Σεπ 2021 · Case Presentation. A 44-year-old white Spanish woman with no significant familiar or medical history was initially diagnosed with a left breast cancer in 2008 (pT2N3M0). The pathology report revealed an ER+, PR-positive, and HER2+ invasive carcinoma of the breast.
